These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 22641747)

  • 1. Continuous ambulatory peritoneal dialysis-related exit-site infections caused by Achromobacter denitrificans and A. xylosoxidans.
    Tsai MT; Yang WC; Lin CC
    Perit Dial Int; 2012; 32(3):362-3. PubMed ID: 22641747
    [No Abstract]   [Full Text] [Related]  

  • 2. Continuous ambulatory peritoneal dialysis-related peritonitis in an uremic outpatient: Achromobacter xylosoxidans.
    Koçak G; Azak A; Huddam B; Yanik S; Duranay M
    Blood Purif; 2012; 34(1):1-2. PubMed ID: 22814104
    [No Abstract]   [Full Text] [Related]  

  • 3. A rare cause of peritoneal dialysis-related peritonitis: Achromobacter denitrificans.
    Cankaya E; Keles M; Gulcan E; Uyanik A; Uyanik H
    Perit Dial Int; 2014; 34(1):135-7. PubMed ID: 24525606
    [No Abstract]   [Full Text] [Related]  

  • 4. Fatal catheter-related bacteremia due to Alcaligenes (Achromobacter) xylosoxidans in a hemodialysis patient.
    Turgutalp K; Kiykim A; Ersoz G; Kaya A
    Int Urol Nephrol; 2012 Aug; 44(4):1281-3. PubMed ID: 21637989
    [No Abstract]   [Full Text] [Related]  

  • 5. Case report: The first case of Achromobacter xylosoxidans-related tunnel infection in a patient receiving peritoneal dialysis.
    Tsai JL; Tsai SF
    Medicine (Baltimore); 2017 Apr; 96(16):e6654. PubMed ID: 28422870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and microbiological evaluation of eight patients with isolated Achromobacter xylosoxidans.
    Atalay S; Ece G; Samlioğlu P; Kose S; Maras G; Gonullu M
    Scand J Infect Dis; 2012 Oct; 44(10):798-801. PubMed ID: 22404460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dialysis-associated Alcaligenes xylosoxidans peritonitis: a pediatric case.
    Melgosa M; Espinazo O; Alonso A; García Perea A; Navarro M
    Perit Dial Int; 2004; 24(1):72-5. PubMed ID: 15104341
    [No Abstract]   [Full Text] [Related]  

  • 8. Achromobacter xylosoxidans, an emerging pathogen in catheter-related infection in dialysis population causing prosthetic valve endocarditis: a case report and review of literature.
    Ahmed MS; Nistal C; Jayan R; Kuduvalli M; Anijeet HK
    Clin Nephrol; 2009 Mar; 71(3):350-4. PubMed ID: 19281752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infective endocarditis caused by Achromobacter xylosoxidans: a case report and review of the literature.
    Tokuyasu H; Fukushima T; Nakazaki H; Shimizu E
    Intern Med; 2012; 51(9):1133-8. PubMed ID: 22576403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CAPD-associated peritonitis caused by Alcaligenes xylosoxidans sp. xylosoxidans.
    Tang S; Cheng CC; Tse KC; Li FK; Choy BY; Chan TM; Lai KN
    Am J Nephrol; 2001; 21(6):502-6. PubMed ID: 11799270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peritoneal Dialysis-Associated Peritonitis Caused by
    Tawhari I; Saggese S; Alshahrani SS; Asiri G; Alshahrani SA; Summan S; Al Qasim YY; Al Majbar YA
    J Investig Med High Impact Case Rep; 2024; 12():23247096231220467. PubMed ID: 38164897
    [No Abstract]   [Full Text] [Related]  

  • 12. Achromobacter xylosoxidans Infections after Prostate Biopsies, France, 2014.
    Amoureux L; Bador J; Neuwirth C
    Emerg Infect Dis; 2019 Nov; 25(11):2158-2159. PubMed ID: 31625846
    [No Abstract]   [Full Text] [Related]  

  • 13. Marked increase in incidence of Achromobacter xylosoxidans infections caused by sporadic acquisition from the environment.
    Ridderberg W; Bendstrup KE; Olesen HV; Jensen-Fangel S; Nørskov-Lauritsen N
    J Cyst Fibros; 2011 Dec; 10(6):466-9. PubMed ID: 21835703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of Achromobacter xylosoxidans bacteremia in northern Taiwan.
    Shie SS; Huang CT; Leu HS
    J Microbiol Immunol Infect; 2005 Aug; 38(4):277-82. PubMed ID: 16118676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Achromobacter xylosoxidans colonisation in bronchiectasis].
    Gázquez G
    Enferm Infecc Microbiol Clin; 2010 Dec; 28(10):758-9; author reply 759. PubMed ID: 20846757
    [No Abstract]   [Full Text] [Related]  

  • 16. Achromobacter xylosoxidans induced bronchiolitis obliterans in cystic fibrosis.
    De Baets F; Schelstraete P; Haerynck F; Van Biervliet S; De Bruyne R; Franckx H; Van Daele S
    Pediatr Pulmonol; 2014 Apr; 49(4):414-6. PubMed ID: 24039244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Achromobacter xylosoxidans in two haemodialysis patients.
    Palacios-Gómez ME; Martín-Gómez A; García-Marcos S
    Nefrologia; 2014; 34(4):538-9. PubMed ID: 25036074
    [No Abstract]   [Full Text] [Related]  

  • 18. Infection of a total hip prosthesis in a dog caused by Achromobacter(Alcaligenes) xylosoxidans.
    Girling SL; Innes JF
    J Small Anim Pract; 2006 Dec; 47(12):747-50. PubMed ID: 17201829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fatal bacteremia as a complication of hepatic abscess due to Achromobacter xylosoxidans: presentation as a complication in a patient with diabetes mellitus and liver cirrhosis].
    Fernandez-Luque JL; Medina Morales B; Grandez-Urbina JA
    Rev Gastroenterol Peru; 2018; 38(2):209-210. PubMed ID: 30118471
    [No Abstract]   [Full Text] [Related]  

  • 20. Keratitis Due to Achromobacter xylosoxidans in a Contact Lens User.
    Almenara Michelena C; Del Buey MÁ; Ascaso FJ; Cristóbal JÁ
    Eye Contact Lens; 2018 Sep; 44 Suppl 1():S348-S351. PubMed ID: 28350622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.